Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasis
Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasis
复制标题
DOI:
10.1016/j.celrep.2022.110444
复制
发表时间:
2022-03-01
期刊:
影响因子:
8.8
通讯作者:
Yoshimori, Tamotsu
中科院分区:
文献类型:
--
作者:
Yamamoto-Imoto, Hitomi;Minami, Satoshi;Yoshimori, Tamotsu
Accumulation of senescent cells affects organismal aging and the prevalence of age-associated disease. Emerging evidence suggests that activation of autophagy protects against age-associated diseases and promotes longevity, but the roles and regulatory mechanisms of autophagy in cellular senescence are not well understood. Here, we identify the transcription factor, MondoA, as a regulator of cellular senescence, autophagy, and mitochondrial homeostasis. MondoA protects against cellular senescence by activating autophagy partly through the suppression of an autophagy-negative regulator, Rubicon. In addition, we identify peroxiredoxin 3 (Prdx3) as another downstream regulator of MondoA essential for mitochondria! homeo- stasis and autophagy. Rubicon and Prdx3 work independently to regulate senescence. Furthermore, we find that MondoA knockout mice have exacerbated senescence during ischemic acute kidney injury (AKI), and a decrease of MondoA in the nucleus is correlated with human aging and ischemic AKI, Our results suggest that decline of MondoA worsens senescence and age-associated disease.